
A journal of the @AmThyroidAssn. Covers the latest clinical #thyroid research & issues. Editor: @DoctorAngell | CT for the Public: @thyroidfriends
Joined October 2018
- Tweets2.1K
- Following5.5K
- Followers8.2K
- Likes502
It's October 2026! This month's issue is out &ready to read! Find expert reviews on new clinical #thyroid research.
ow.ly/UPc150ZYYSW
#endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism @AmThyroidAssn #thyroid #GravesDisease
This issue's great commentary on data in @thyroidjournal For #RAS positive #thyroidnodules w/ #Bethesda III/IV #cytology, ~50% #thyroidcancer when resected, but 91% of those monitored remain unoperated over time. What should the right management be?
ow.ly/ZENI50ZG8SY
This review: Dr. de Leo analyzes how #resistance to selective #RET inhibitor can develop both in RET & #MAPK pathway activation. Preclinical data show selpercatinib+trametinib can give sustained tumor response.
ow.ly/zh6B50ZG8Q8
#thyroidcancer #RAIR @Simonedeleo86
What infants/children should get #thyroid testing after iodinated contrast? Dr. Cherella @BostonChildrens comments on more personalized guidance pub'd in #Pediatrics challenging broader #FDA recommendations.
ow.ly/FAVc50ZG8Kn
#pediatrics #thyroidfunction #hypothyroidism
There are #Endocrine Disrupting Chemicals (#EDC) in personal care products linked to altered #thyroid labs, #TSH #FT4 #TPO. Joris Osinga reviews new data on the effects during early-to-mid #pregnancy.
ow.ly/Tjiy50ZG8Fj
#phthalates # polyfluoroalkyl # bisphenols
Can #ActiveSurveillance be considered for larger #papillary #thyroidcancer? More data now on the monitoring in carefully selected #PTC >1.5 cm, with delayed #surgery effective. Dr. Fernanda Vaisman provides analysis online now!
ow.ly/C2SP50ZG8oT
#thyroid #thyroidectomy
Online read: Data on #ThyroidPrint evaluation of indeterminate #thyroidnodules reviewed by Dr. Sohie Dream, MD shows molecular ‘benign’ #Bethesda III & IV nodules unlikely to grow over 5 years.
ow.ly/subH50ZG8k5
#thyroidnodule #moleculartesting #FNA #thyroidcancer
August issue alert: Dr. Hashimoto looks at article indicating dramatic short-term improvement, but frequent regression in patients treated w/ #teprotumumab for #thyroideyedisease.
ow.ly/bbRI50ZG8g0
#TED #GravesDisease #thyroid #hyperthyroidism
Can #ultrasound show when toxic #thyroidnodules need biopsy? @NataliaGenereMD reviews new data showing #ACR #TIRADS identified malignant nodules, but benign #nodule features overlapped.
ow.ly/Iz8t50ZG88C
#thyroidcancer #FNA #thyroidcancer #hyperthyroidism #thyroid
Treatment of #hypothyroidism w/ #T3 –what's the latest? Dr. Mammen unpacks a new metaanalysis indicating how adverse outcomes occur & can maybe be avoided.
ow.ly/jY4O50ZwBHg
#liothyronine #endotwitter #medtwitter #thyroid @Sage_Publishing @TheEndoSociety #JCEM
It's August 2026! This month's issue is out &ready to read! Find expert reviews on new clinical #thyroid research.
ow.ly/VBsJ50ZG7QV
#endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism @AmThyroidAssn #thyroid #GravesDisease
Read/download expert reviews in the June issue covering the latest in Clinical #Thyroid.
ow.ly/ZmNj50ZG81E
#endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism #Hashimotos #thyroiditis #iodine @ThyCaInc @GDATF @Medscape @EndocrineToday
The latest in how #ArtificialIntelligence is changing the game for #thyroidnodule evaluation. @DavidToroT discusses the data in #ClinicalThyroiology.
ow.ly/x0Rq50ZwBtb
#endotwitter #medtwitter #thyroid @Sage_Publishing
Dr. Natalia Genere highlights new data on the long-term prognosis of #pediatric #thyroidcancer to inform follow up and #survivorship.
ow.ly/wAMy50ZwBcr
#endotwitter #medtwitter #thyroid @thancfoundation @ThyCaInc #DTC @Sage_Publishing
Dr. Fernanda Vaisman discusses population-based analysis showing improved survival associated w/ #RadioActiveIodine across #thyroidcancer subgroups.
ow.ly/Awyl50ZwB6c
#endotwitter #medtwitter #thyroid @thancfoundation @ThyCaInc #DTC. @Sage_Publishing
Dr. Marika Russell discusses study in @thyroidjournal on #Neoadjuvant kinase inhibitors for advanced or unresectable differentiated #ThyroidCancer.
ow.ly/YVhU50ZwAV2
@MassEyeAndEar #endotwitter #medtwitter #thyroid @thancfoundation @ThyCaInc #MKI #DTC
The 2025 @AmThyroidAssn #thyroidcancer guidelines on completion #thyroidectomy. Dr. Robenshtock and Ghaznavi discuss who needs what.
ow.ly/zTiL50ZwAFV
#endotwitter #medtwitter #thyroid @thancfoundation @ThyCaInc @thyroidjournal @Sage_Publishing
Is there a use of #RadioFrequencyAblation for #GravesDisease? Drs. Christine O'Neill & Catherine Sinclair discuss the implications of new data.
ow.ly/aAq050ZwAyF
#endotwitter #medtwitter @NASITablate #thyroid #RFA #ablation @Sage_Publishing
Reviewing the new 2025 ATA #Guidelines for #DTC. This time, Dr. Vaisman reviews when the local rather than systemic needs to be considered for advanced #thyroidcancer. Click, read, or download.
ow.ly/TbsH50Zrk1O
#medtwitter #endotwitter #thyroid #RAIR #TKI
Beyond the orbitals: Dr. Gao reviewed a new study in @thyroidjournal on the long-term risk of #prediabetes, #diabetes after # teprotumumab therapy for #ThyroidEyeDisease. Read now in @clinicalthyroid
ow.ly/B43L50ZsoQ0
#medtwitter #endotwitter #thyroid #GravesDisease #T2DM



















